Episodes
-
Advances in the Management of Amyloid Light Chain Amyloidosis with Dr Morie Gertz
April 30th, 2021 | Season 1 | 57 mins 4 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of amyloid light chain amyloidosis with Dr Morie Gertz, moderated by Dr Neil Love.
-
Advances in the Management of Cholangiocarcinoma with Dr Mitesh Borad
April 29th, 2021 | Season 1 | 40 mins 6 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on novel targeted approaches in the management of cholangiocarcinoma with Dr Mitesh Borad, moderated by Dr Neil Love.
-
Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst
April 12th, 2021 | Season 1 | 39 mins 1 sec
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the latest advances in adjuvant therapy for early-stage non-small cell lung cancer with EGFR tumor mutations with Dr Roy Herbst, moderated by Dr Neil Love.
-
Key Presentations on Non-Hodgkin and Hodgkin Lymphomas from the 2020 ASH Annual Meeting with Dr Laurie Sehn
April 7th, 2021 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on selected data sets in non-Hodgkin and Hodgkin lymphomas from the 2020 ASH Annual Meeting with Dr Laurie Sehn, moderated by Dr Neil Love.
-
Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander
April 2nd, 2021 | Season 1 | 1 hr 3 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on important data sets on multiple myeloma, Waldenström macroglobulinemia and amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander, moderated by Dr Neil Love.
-
Side Effects of Hormonal Therapy in Prostate Cancer with Dr Roberto Iacovelli
March 29th, 2021 | Season 1 | 47 mins 36 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on hormonal therapies and the associated side effects in prostate cancer with Dr Roberto Iacovelli, moderated by Dr Neil Love.
-
Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba
March 26th, 2021 | Season 1 | 1 hr 6 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on important data sets on acute myeloid leukemia and myelodysplastic syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba, moderated by Dr Neil Love.
-
Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer with Dr Manmeet Ahluwalia
March 23rd, 2021 | Season 1 | 1 hr 4 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the treatment of CNS metastases in patients with non-small cell lung cancer with Dr Manmeet Ahluwalia, moderated by Dr Neil Love.
-
Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
March 22nd, 2021 | Season 1 | 1 hr 12 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the treatment of diffuse large B-cell lymphoma with Dr Gilles Salles, moderated by Dr Neil Love.
-
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei
March 19th, 2021 | Season 1 | 54 mins 15 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the treatment of acute myeloid leukemia not eligible for intensive induction therapy with Dr Andrew Wei, moderated by Dr Neil Love.
-
PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín
March 12th, 2021 | Season 1 | 44 mins 41 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the use of PARP inhibitors in ovarian cancer with Dr Antonio González-Martín, moderated by Dr Neil Love.
-
Predictors of Response to Cancer Immunotherapy with Prof Solange Peters
March 12th, 2021 | Season 1 | 1 hr 11 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on predictors of response to cancer immunotherapy with Prof Solange Peters, moderated by Dr Neil Love.
-
Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael
March 10th, 2021 | Season 1 | 45 mins 52 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on newly approved agents in multiple myeloma with Dr Joseph Mikhael, moderated by Dr Neil Love.
-
Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska
March 8th, 2021 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on new targets in non-small cell lung cancer with Dr Zofia Piotrowska, moderated by Dr Neil Love.
-
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
March 3rd, 2021 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on newly approved and emerging therapies for HER2-positive metastatic breast cancer with Dr Mark Pegram, moderated by Dr Neil Love.
-
Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson
March 1st, 2021 | Season 1 | 1 hr 17 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussions on the role of minimal residual disease evaluation in the management of multiple myeloma and chronic lymphocytic leukemia with Drs Shaji Kumar and Philip Thompson, moderated by Dr Neil Love.